Here, brand new data from a study by the Cell and Gene Therapy Catapult, completed in June 2021 is presented. It shows that a significant increase in yield and quality of an AAV was realized from a timed osmolality shift. Additionally, this data will show how the shift had a profound effect on the relative extracellular vs intracellular vector yield, with the potential to significantly reduce time and costs within viral vector manufacturing.
Please fill out this brief form to download this content.
